aluminum phosphate has been researched along with Severe Acute Respiratory Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bottazzi, ME; Curti, E; Du, L; Hotez, PJ; Jiang, S; Jones, K; Lustigman, S; Tseng, CT; Zhan, B | 1 |
1 other study(ies) available for aluminum phosphate and Severe Acute Respiratory Syndrome
Article | Year |
---|---|
Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome.
Topics: Adjuvants, Immunologic; Aluminum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antigens, Viral; Clinical Trials as Topic; Humans; Lipid A; Membrane Glycoproteins; Phosphates; Protein Structure, Tertiary; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Vaccines, Subunit; Vaccines, Synthetic; Viral Envelope Proteins; Viral Vaccines | 2012 |